Following the decline in educational institutions since COVID-19, more and more learning complexes and buildings are being ...

Q3 2025 Earnings Call Transcript February 14, 2025 8:00 AM ETCompany ParticipantsAndrew Arnovitz - Senior VP, Investor Relations ...

And how they implement it to improve and better themselves. Watch any Olympic event, and you’ll notice this universal ritual: The moment an athlete completes their performance, they turn to their ...

Q4 2024 Results Conference Call February 13, 2025 8:00 AM ETCompany ParticipantsLouis Schmid - Head of Investor ...

Emil Kakkis; President, Chief Executive Officer, Director; Ultragenyx Pharmaceutical Inc Erik Harris; Executive Vice President, Chief Commercial Officer; Ultragenyx Pharmaceutical Inc Howard Horn; ...

CAE Inc (NYSE:CAE). reported its fourth-quarter 2024 earnings, surpassing both earnings per share (EPS) and revenue forecasts. The company's EPS came in at $0.29, slightly above the forecasted $0.28.